MobbleOpen in Mobble ⇢
Science · Biology & genetics · published 2026-10-06 · via Medical Xpress

Local crop-based therapeutic foods could improve malnutrition treatment reach in Africa

Researchers have developed a therapeutic food formulation using locally available ingredients—chickpeas, sorghum, corn, and soybeans—to treat severe childhood malnutrition in sub-Saharan Africa. Current treatments reach only about 30% of affected children partly because conventional formulations rely on expensive imported ingredients like powdered milk. Producing therapeutic foods from regional crops could reduce costs and supply chain dependencies while expanding access to this proven treatment.

Expanded Detail

Severe childhood malnutrition remains a treatable condition, yet fewer than one-third of affected children in sub-Saharan Africa currently access proven interventions. This treatment gap stems largely from the reliance on imported, expensive ingredients like powdered milk and peanuts in standard formulations. Researchers tested an alternative combining locally cultivated chickpeas, sorghum, corn, and soybeans—ingredients already established in regional agriculture.

The plant-based formulation demonstrated superior nutritional metrics compared to conventional products, delivering higher protein density and quality scores. Crucially, updated international nutritional guidelines have recently eliminated mandatory dairy requirements, enabling regionally produced alternatives to meet established health standards. This regulatory shift removes a significant barrier to implementing locally sourced therapeutic foods.

Context

If successfully implemented, locally produced therapeutic foods could reshape childhood malnutrition treatment accessibility across sub-Saharan Africa. By reducing import dependency and production costs, such formulations may extend treatment availability beyond the current 30% coverage. The approach could strengthen regional food systems while mitigating vulnerabilities from supply chain disruptions caused by conflict or climate pressures. However, scaling from preclinical testing to widespread clinical deployment would require validation in diverse populations, investment in local production infrastructure, and sustained healthcare system support.

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Medical Xpress →
Related stories
Engineered Antibodies Provide Extended Relief From Nerve Pain While Preserving Protective Sensation · Neuroscience
Nanoparticle therapy targeting lung tumors simultaneously reduces cancer and cancer-related muscle wasting · Biology & genetics
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Locally grown crops could expand access to childhood malnutrition treatment.” Browse more stories.